Growing Pains: Challenges for Tomorrow's Bioscience Facilities

Conference Agenda

7:30 am Registration and Continental Breakfast

8:00 am Opening Remarks
Welcome. Sue Markland Day, President Bay Area Bioscience Center
Welcome. Joe Fernekes, Mayor City of South San Francisco
What to Expect from this Program. Scott Morrison (Ernst &Young) and BABC Chair

8:25 am Keynote Speaker
David Martin, Jr. M.D., President & CEO (EOS Biotechnology)

9:00 am Growth Strategies
John Sung (Gilead Sciences)
Brian Cunningham (Rigel, Inc)
Mike Edwards (Genentech)

10:00am “Bioscience and Real Estate: Navigating a Complex Market,”. Dino Perazzo (CB Richard Ellis)

10:30am Coffee Break/ Exhibits/ Networking

11:00am Breakout Session One
Track #1 "Getting Started: Procurement of Space," Dan Hipple (Advanced Medicine) and Chris Jacobs (CB Richard Ellis)
Track #2 "Once You Are Established: Case Studies," Richard Reitz, Ph.D. and Bryan Croeni, AIA (MBT Architecture)
Track #3 "Transition of Biotechnology Products to Commercialization: Manufacturing Small Molecules," Regan Shea (Gilead Sciences)
Track #4 "Regional Infrastructure" Sean Randolph, Ph.D. (Bay Area Economic Forum)

11:45pm Lunch & Speaker
"Energy: Bay Area Myths and Realities," Tom Vacar KTVU

1:15 pm Breakout Session Two
Track #1 "Getting Started: Consideration in Design," Douglas White, AIA (WHL) and Robert A. Bracamonte, AIA (HDR)
Track #2 "Once You Are Established: The Tools," Richard Reitz, Ph.D., Kay Kornovich, AIA, and John McDonald, P.E.
Track #3 "Transition of Biotechnology Products to Commercialization: Contract Manufacturing," Kent Iverson (Corixa)
Track #4 "Regional Infrastructure: Water Quality and Availability," John Gibbs (City of South San Francisco Department of Public Works

2:00 pm Ask the Experts Roundtable Session 1

2:45 pm Breakout Session Three
Track #1 "Getting Started: How to Build It" Gavin Keith (DPR) and Rick Millitello (Rudolph &Sletten)
Track #2 "Once You Are Established: Buying Real Estate," Maureen Wong (Chiron) and Raul Campos (Consultant)
Track #3 "Transition of Biotechnology Products to Commercialization: Manufacturing Proteins/Biologics," Scott Zimmerman (Genentech)
Track #4 "Regional Infrastructure: Current Health and Safety Issues Facing Biotechnology Companies," Hilary McNulty (COR Therapeutics)

3:30 pm Coffee Break/ Exhibits/Networking

4:00 pm Ask the Experts Roundtable Session 2

4:45 pm "Biotech 2001," Steve Burrill, President & CEO (Burrill & Company)

5:30 pm Conference Wrap-up. Sue Markland Day and Reception.